No black box warning on record for Ruconest
As of the latest FDA labeling reviewed, Ruconest (C1 ESTERASE INHIBITOR RECOMBINANT) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ruconest medicine page for the complete safety profile.